CSP
AVNS

Cary Street Partners’s Avanos Medical AVNS Stock Holding History

Cary Street Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,750
Closed -$188K – 988
2025
Q4 		$188K Sell
16,750
-1,725
-9% -$19.7K ﹤0.01% 852
2025
Q3 		$214K Buy
18,475
+2,700
+17% +$31.6K 0.01% 775
2025
Q2 		$193K Buy
15,775
+11
+0.1% +$138 0.01% 777
2025
Q1 		$226K Buy
+15,764
New +$246K 0.01% 712

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Cary Street Partners's AVNS Position: Q1 2026 in Review

Cary Street Partners sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 16,750 shares — an estimated $188K sold.

Cary Street Partners first reported a position in AVNS in Q1 2025 and held it in 4 quarters. The position peaked at $226K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Cary Street Partners reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Cary Street Partners sold 16,750 Avanos Medical shares in Q1 2026, an estimated $188K.
  • Cary Street Partners first reported a position in Avanos Medical in Q1 2025 and held it in 4 quarters.
  • Cary Street Partners's Avanos Medical position peaked at $226K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Cary Street Partners's 13F filing for Q1 2026, filed 29 Apr 2026.